Filing Details

Accession Number:
0001104659-19-047347
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-08-26 21:34:34
Reporting Period:
2019-08-21
Accepted Time:
2019-08-26 21:34:34
Original Submission Date:
2019-08-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Plc NBRV Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711517 Maria Francesco Lavino 1000 Continental Drive
Suite 600
King Of Prussia PA 19406
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-08-21 3,797 $2.08 11,172 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019.